Intercept to Announce Third Quarter 2020 Financial Results on November 9, 2020
November 02 2020 - 4:00PM
Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat progressive non-viral liver diseases, will
announce its third quarter 2020 financial results prior to market
open on Monday, November 9, 2020. The announcement will be followed
by a conference call and audio webcast hosted by Intercept
management at 8:30 a.m. ET to discuss the results.
The conference call will be available on the investor page of
our website at http://ir.interceptpharma.com or by calling (855)
232-3919 (toll-free domestic) or (315) 625-6894 (international)
passcode 3798851. Archived webcasts will be available on
Intercept’s website for approximately two weeks.
About InterceptIntercept is a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat progressive non-viral liver diseases,
including primary biliary cholangitis (PBC) and nonalcoholic
steatohepatitis (NASH). Founded in 2002 in New York, Intercept has
operations in the United States, Europe and Canada. For more
information, please visit www.interceptpharma.com or connect with
the company on Twitter and LinkedIn.
CONTACT
For more information about Intercept, please contact:
Investor inquiries: investors@interceptpharma.com
Media inquiries: media@interceptpharma.com
Source: Intercept Pharmaceuticals, Inc.
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Sep 2023 to Sep 2024